Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer with PSA Screening By Ogkologos - November 4, 2025 246 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ERSPC study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Lurbinectedin Zongertinib Shows Durable Antitumour Activity in First-Line Treatment for Patients with Previously Untreated HER2-mutated Advanced NSCLC Patient Guide on Immunotherapy Side Effects and Their Management Now Available Also in the Ukrainian MOST POPULAR ESMO Congress 2024 Barcelona, Spain, 13-17 September September 3, 2024 Promising Results Are Provided by Tebentafusp in Metastatic Uveal Melanoma December 12, 2020 FDA Approves Selpercatinib for Locally Advanced or Metastatic RET Fusion-Positive NSCLC September 29, 2022 High School Holds Early Graduation Ceremony For Teen With Terminal Cancer November 28, 2021 Load more HOT NEWS One in Five of Older Patients with EBC Treated in a... Science Surgery: ‘How are children’s cancers different from adult’s cancers?’ First Global Estimates of Cervical Cancer Attributable to HIV ΚΑΡΚΙΝΟΣ ΗΠΑΤΟΣ
